KBA, Brownback in showdown over spending

Kansas Gov. Sam Brownback is urging the Kansas Bioscience Authority to impose a moratorium on new investments after an audit raised pointed questions about the activities of its former director. But the KBA told reporters that it plans to push ahead. In the meantime, Brownback is holding back $22 million in new funding for the authority. Report

Suggested Articles

AbbVie snagged the option to license Harpoon’s anti-BCMA multiple myeloma candidate and the duo added up to six new targets to their discovery deal.

In this week's EuroBiotech Report, Bayer's heart failure drug clears phase 3 test, ABPI calls for more U.K. investment and GHO raises €975 million. 

In our EuroBiotech roundup this week, Azeria raises £32 million, Zealand delays phase 3 readout and Galapagos eyes early 2021 IPF futility analysis.